Lab receives NIH funding to focus on a key extracellular matrix protein involved in retinal diseases

The Hulleman Lab recently received a 5-year R01 grant from the National Eye Institute. This grant will focus on developing a better understanding of the role of the extracellular matrix protein, fibulin-3 (F3) in the rare macular dystrophy, Malattia Leventinese, and the more common disease, age-related macular degeneration (AMD).